BioMimir
BioMimir is a B2B medical device company specializing in regenerative technology, focusing on purpose-designed biomimetic polymers for next-generation tissue regeneration. They develop affordable, scalable, and globally deployable solutions for wound healing, inspired by nature to replicate the structure and function of features in plants, animals, and human tissues. Their core innovation involves anti-inflammatory and pro-regenerative biomimetic polymers that mimic the body's extracellular matrix, aiming to prevent scar tissue and enhance clinical outcomes.
Industries
Nr. of Employees
small (1-50)
BioMimir
Products
Bioresorbable liquid-to-solid wound filler (lead development candidate)
A bioresorbable skin substitute concept that transitions from liquid to solid in situ to fill complex wounds and reduce scarring; described as the company's proof-of-concept lead candidate for treatment of ulcers, abscesses, and fistulas.
Bioresorbable liquid-to-solid wound filler (lead development candidate)
A bioresorbable skin substitute concept that transitions from liquid to solid in situ to fill complex wounds and reduce scarring; described as the company's proof-of-concept lead candidate for treatment of ulcers, abscesses, and fistulas.
Services
B2B development and supply of biomimetic polymers
Development and provision of regenerative biomaterial solutions for business customers, including design and manufacture of biomimetic polymer products for wound treatment.
Research collaborations and preclinical development
Collaborative R&D and translational research support for biomaterials development, including preclinical proof-of-concept studies and publication-driven research.
B2B development and supply of biomimetic polymers
Development and provision of regenerative biomaterial solutions for business customers, including design and manufacture of biomimetic polymer products for wound treatment.
Research collaborations and preclinical development
Collaborative R&D and translational research support for biomaterials development, including preclinical proof-of-concept studies and publication-driven research.
Expertise Areas
- Regenerative medicine
- Biomaterials and polymer chemistry
- Wound care device development
- Medical device manufacturing and quality systems (ISO 13485 familiarity)
Key Technologies
- Biomimetic polymer design
- Bioresorbable polymer formulations
- Liquid-to-solid wound filler systems
- Extracellular matrix-mimicking materials